- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by EUSA Pharma (US), Inc.
Total 194 results
-
Horizon Pharma USA, Inc.Terminated
-
Horizon Pharma USA, Inc.CompletedCystic FibrosisUnited States
-
Horizon Pharma USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Horizon Pharma USA, Inc.CompletedCystinosisFrance, United States, Netherlands
-
Horizon Pharma USA, Inc.Completed
-
Teikoku Pharma USA, Inc.CompletedIrritation/IrritantUnited States
-
Horizon Pharma USA, Inc.CompletedThyroid-Associated Ophthalmopathy | Thyroid Associated OphthalmopathiesUnited Kingdom, United States, Germany, Italy
-
Horizon Pharma USA, Inc.CompletedCystic Fibrosis (CF)Germany, United States, Netherlands
-
Horizon Pharma USA, Inc.CompletedCystic FibrosisUnited States
-
Horizon Pharma USA, Inc.CompletedInherited Mitochondrial Disease, Including Leigh SyndromeUnited States
-
Teikoku Pharma USA, Inc.Completed
-
Teikoku Pharma USA, Inc.Completed
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye Disease | Chronic (Inactive) Thyroid Eye DiseaseUnited States
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye DiseaseUnited States
-
Advanced Research NetworkAstellas Pharma US, Inc.TerminatedOver-Active BladderUnited States
-
St. Louis UniversityAstellas Pharma US, Inc.WithdrawnCoronary Artery DiseaseUnited States
-
Cardiovascular Imaging TechnologiesAstellas Pharma US, Inc.UnknownCoronary Artery DiseaseUnited States
-
Cleveland Clinic FloridaAstellas Pharma US, Inc.UnknownOveractive Bladder | Urinary Tract InfectionUnited States
-
Astellas Pharma IncAjinomoto USA, INC.CompletedType 2 Diabetes Mellitus | Diabetes Mellitus, Type IIJapan
-
East Carolina UniversityAstellas Pharma US, Inc.CompletedKidney TransplantationUnited States
-
Johns Hopkins UniversityAstellas Pharma US, Inc.CompletedOveractive Bladder | Urinary Incontinence | Erectile DysfunctionUnited States
-
The Cleveland ClinicAstellas Pharma US, Inc.Terminated
-
University of PittsburghAstellas Pharma US, Inc.Completed
-
University of PittsburghAstellas Pharma US, Inc.CompletedLung Transplantation | Fungal InfectionsUnited States
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingLiposarcoma, DedifferentiatedUnited States
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingUlcerative ColitisUnited States
-
Gary E. Stein, Pharm.D.Astellas Pharma US, Inc.CompletedCandidemiaUnited States
-
M.D. Anderson Cancer CenterArchimedes Pharma US, Inc.Terminated
-
University of California, IrvineAstellas Pharma US, Inc.CompletedUrinary IncontinenceUnited States
-
University of Wisconsin, MadisonAstellas Pharma US, Inc.CompletedCoronary Artery DiseaseUnited States
-
Rush University Medical CenterAstellas Pharma US, Inc.CompletedAtopic DermatitisUnited States
-
Luca SzalontayMidatech Pharma US Inc.CompletedDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Diffuse Pontine and Thalamic GliomasUnited States
-
University of Maryland, BaltimoreAstellas Pharma US, Inc.CompletedCardiac FunctionUnited States
-
Cedars-Sinai Medical CenterAstellas Pharma US, Inc.CompletedCoronary Artery DiseaseUnited States
-
John MurrayAstellas Pharma US, Inc.TerminatedChronic Plaque Psoriasis
-
Brigham and Women's HospitalAstellas Pharma US, Inc.CompletedFebrile NeutropeniaUnited States
-
Northwestern UniversityAstellas Pharma US, Inc.; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering...CompletedHeart Disease, Ischemic | Atherosclerosis, CoronaryUnited States
-
Horizon Pharma USA, Inc.Forest LaboratoriesCompletedCystic FibrosisUnited States, Australia, Israel, New Zealand, Canada
-
Horizon Pharma USA, Inc.Forest LaboratoriesCompletedTrial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients (TIS)Cystic FibrosisUnited States, Ireland, United Kingdom, France, Germany, Israel
-
Shanghai YingLi Pharmaceutical Co. Ltd.Yingli Pharma US, IncRecruiting
-
Shanghai YingLi Pharmaceutical Co. Ltd.Yingli Pharma US, IncRecruitingAdvanced Solid TumorUnited States
-
Prem SomanAstellas Pharma US, Inc.Terminated
-
Medical University of South CarolinaAstellas Pharma US, Inc.CompletedCardiovascular Diseases | Coronary Artery DiseaseUnited States
-
Oregon Health and Science UniversityAstellas Pharma US, Inc.Completed
-
University of NebraskaGE Healthcare; Astellas Pharma US, Inc.CompletedCoronary Artery Disease | Myocardial Perfusion AbnormalitiesUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedHematologic Malignancy | Myeloproliferative DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedEGFR-Mutant Lung CancerUnited States
-
University of Illinois at ChicagoAstellas Pharma US, Inc.CompletedKidney TransplantationUnited States
-
Washington University School of MedicineAstellas Pharma US, Inc.CompletedIschemic Heart DiseaseUnited States